What is the current annual cash & cash equivalents of MRK?

As of today, MRK annual cash & cash equivalents is $14.69B

What is 1-year change in MRK annual cash & cash equivalents?

MRK annual cash & cash equivalents is up +6.72% year-over-year

What is 3-year change in MRK annual cash & cash equivalents?

MRK annual cash & cash equivalents is up +10.69% over the past 3 years

How far is MRK annual cash & cash equivalents from its all-time high?

MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013

How does MRK annual cash & cash equivalents rank versus sector peers?

MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector

When is MRK next annual earnings release?

As of today, the next annual earnings release for MRK has not been scheduled

What is the current quarterly cash & cash equivalents of MRK?

As of today, MRK quarterly cash & cash equivalents is $7.18B

What is MRK quarterly cash & cash equivalents most recent change?

MRK quarterly cash & cash equivalents was up +24.41% on June 30, 2026

What is 1-year change in MRK quarterly cash & cash equivalents?

MRK quarterly cash & cash equivalents is down -17.11% year-over-year

How far is MRK quarterly cash & cash equivalents from its all-time high?

MRK quarterly cash & cash equivalents is currently -67.73% below its historical high of $22.26B set on September 30, 2009

How does MRK quarterly cash & cash equivalents rank versus sector peers?

MRK quarterly cash & cash equivalents is higher than 98.67% of companies in Healthcare sector

When is MRK next earnings release?

The next earnings release for MRK is on October 29, 2026

MRK Cash & Equivalents History & Chart Since 1980

Annual Cash & Cash Equivalents

$14.69B$925.00M+6.72%

December 31, 2025

Summary

Current Value: As of today, MRK annual cash & cash equivalents is $14.69B, up +6.72% on December 31, 2025
Historical Performance: MRK annual cash & cash equivalents is up +10.69% over the past 3 years, up +82.48% over the past 5 years
All-Time High Comparison: MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013
3-Year Low Comparison: MRK annual cash & cash equivalents is +105.14% above its 3-year low of $7.16B reached on December 31, 2023
Sector Comparison: MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

MRK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$14.69B	+6.7%	+10.7%	+82.5%	+20.4%
Quarterly Cash & Cash Equivalents	Jun 30, 26	$7.18B	-17.1%	+11.8%	-16.2%	-48.6%
Price	Aug 21, 26	$152.55	+77.2%	+39.1%	+93.9%	+411.4%
Annual Current Assets	Dec 31, 25	$43.52B	+12.2%	+21.8%	+56.7%	+49.7%
Annual Total Liabilities	Dec 31, 25	$84.20B	+19.0%	+33.4%	+27.2%	+71.9%
Annual Working Capital	Dec 31, 25	$15.19B	+46.6%	+32.3%	+3375.7%	+13.2%
Annual Net Income	Dec 31, 25	$18.26B	+6.6%	+25.7%	+303.8%	+1763.6%

Cash and Cash Equivalents Highs

MRK Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$14.69B	Dec 31, 25	at high
5Y	$14.69B	Dec 31, 25	at high
All	$17.49B	Dec 31, 13	-16.0%

Cash and Cash Equivalents Lows

MRK Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$7.16B	Dec 31, 23	+105.1%
5Y	$7.16B	Dec 31, 23	+105.1%
All	$226.61M	Dec 1, 81	+6382.6%

Cash and Cash Equivalents History

Year	Value	Change
2025	$14.69B	+6.7%
2024	$13.77B	+92.2%
2023	$7.16B	-46.0%
2022	$13.27B	+63.9%
2021	$8.10B	+0.6%
2020	$8.05B	-23.0%
2019	$10.45B	+17.9%
2018	$8.86B	+4.3%
2017	$8.50B	-40.7%
2016	$14.34B	+6.8%
2015	$13.43B	-14.6%
2014	$15.72B	-10.1%
2013	$17.49B	+8.3%
2012	$16.14B	+7.8%
2011	$14.97B	+22.7%
2010	$12.20B	+27.0%
2009	$9.60B	+75.1%
2008	$5.49B	-33.3%
2007	$8.23B	-5.5%
2006	$8.71B	-44.3%
2005	$15.64B	+120.6%
2004	$7.09B	+69.9%
2003	$4.17B	-16.1%

Year	Value	Change
2002	$4.97B	+51.3%
2001	$3.29B	-22.8%
2000	$4.25B	+32.9%
1999	$3.20B	-4.6%
1998	$3.36B	+45.3%
1997	$2.31B	+5.9%
1996	$2.18B	-34.9%
1995	$3.35B	+47.6%
1994	$2.27B	+47.2%
1993	$1.54B	+41.0%
1992	$1.09B	-22.5%
1991	$1.41B	+17.9%
1990	$1.20B	+4.7%
1989	$1.14B	-26.2%
1988	$1.55B	+35.0%
1987	$1.15B	+18.9%
1986	$965.80M	+14.7%
1985	$842.00M	+13.1%
1984	$744.32M	+100.8%
1983	$370.74M	+18.4%
1982	$313.24M	+38.2%
1981	$226.61M	-25.0%
1980	$302.27M	-

FAQ

What is the current annual cash & cash equivalents of MRK?: As of today, MRK annual cash & cash equivalents is $14.69B
What is 1-year change in MRK annual cash & cash equivalents?: MRK annual cash & cash equivalents is up +6.72% year-over-year
What is 3-year change in MRK annual cash & cash equivalents?: MRK annual cash & cash equivalents is up +10.69% over the past 3 years
How far is MRK annual cash & cash equivalents from its all-time high?: MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013
How does MRK annual cash & cash equivalents rank versus sector peers?: MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector
When is MRK next annual earnings release?: As of today, the next annual earnings release for MRK has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$7.18B$1.41B+24.41%

June 30, 2026

Summary

Current Value: As of today, MRK quarterly cash & cash equivalents is $7.18B, up +24.41% on June 30, 2026
Historical Performance: MRK quarterly cash & cash equivalents is down -17.11% year-over-year, up +11.83% over the past 3 years
All-Time High Comparison: MRK quarterly cash & cash equivalents is currently -67.73% below its historical high of $22.26B set on September 30, 2009
3-Year Low Comparison: MRK quarterly cash & cash equivalents is +25.76% above its 3-year low of $5.71B reached on March 31, 2024
Sector Comparison: MRK quarterly cash & cash equivalents is higher than 98.67% of companies in Healthcare sector

Performance

MRK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Jun 30, 26	$7.18B	+24.4%	-17.1%	+11.8%	-16.2%
Annual Cash & Cash Equivalents	Dec 31, 25	$14.69B	–	+6.7%	+10.7%	+82.5%
Price	Aug 21, 26	$152.55	+31.6%	+77.2%	+39.1%	+93.9%
Quarterly Current Assets	Jun 30, 26	$36.68B	+4.8%	-1.0%	+22.4%	+28.0%
Quarterly Total Liabilities	Jun 30, 26	$87.82B	+6.1%	+28.3%	+33.6%	+53.3%
Quarterly Working Capital	Jun 30, 26	$8.95B	+10.9%	-18.9%	+35.9%	+32.4%
Quarterly Net Income	Jun 30, 26	-$1.34B	+68.5%	-130.2%	+77.6%	-210.1%

Quarterly Cash & Cash Equivalents Highs

MRK Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$18.25B	Sep 30, 25	-60.6%
3Y	$18.25B	Sep 30, 25	-60.6%
5Y	$18.25B	Sep 30, 25	-60.6%
All	$22.26B	Sep 30, 09	-67.7%

Quarterly Cash & Cash Equivalents Lows

MRK Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$5.77B	Mar 31, 26	+24.4%
3Y	$5.71B	Mar 31, 24	+25.8%
5Y	$5.71B	Mar 31, 24	+25.8%
All	$508.70M	Mar 31, 90	+1311.8%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Jun 2026	$7.18B	+24.4%
Mar 2026	$5.77B	-60.7%
Dec 2025	$14.69B	-19.5%
Sep 2025	$18.25B	+110.6%
Jun 2025	$8.67B	-7.1%
Mar 2025	$9.33B	-32.2%
Dec 2024	$13.77B	-5.9%
Sep 2024	$14.64B	+28.4%
Jun 2024	$11.40B	+99.5%
Mar 2024	$5.71B	-20.2%
Dec 2023	$7.16B	-18.7%
Sep 2023	$8.81B	+37.2%
Jun 2023	$6.42B	-38.4%
Mar 2023	$10.42B	-21.5%
Dec 2022	$13.27B	+16.6%
Sep 2022	$11.38B	+11.5%
Jun 2022	$10.21B	+13.6%
Mar 2022	$8.99B	+11.0%
Dec 2021	$8.10B	-19.2%
Sep 2021	$10.02B	+16.8%
Jun 2021	$8.58B	+22.8%
Mar 2021	$6.98B	-13.3%
Dec 2020	$8.05B	+9.4%
Sep 2020	$7.36B	-33.7%
Jun 2020	$11.10B	+49.4%
Mar 2020	$7.43B	-28.9%
Dec 2019	$10.45B	+30.3%
Sep 2019	$8.02B	+12.9%
Jun 2019	$7.11B	-19.2%
Mar 2019	$8.80B	-0.7%
Dec 2018	$8.86B	-13.8%
Sep 2018	$10.29B	+35.4%
Jun 2018	$7.59B	+3.4%
Mar 2018	$7.35B	-13.6%
Dec 2017	$8.50B	-24.1%
Sep 2017	$11.20B	-6.5%
Jun 2017	$11.97B	-21.5%
Mar 2017	$15.25B	+6.3%
Dec 2016	$14.34B	+9.7%
Sep 2016	$13.07B	+10.4%
Jun 2016	$11.83B	-8.6%
Mar 2016	$12.94B	-3.6%
Dec 2015	$13.43B	+11.1%
Sep 2015	$12.09B	+6.3%
Jun 2015	$11.37B	-27.1%
Mar 2015	$15.60B	-0.8%
Dec 2014	$15.72B	+9.6%
Sep 2014	$14.35B	+7.1%
Jun 2014	$13.40B	-34.7%
Mar 2014	$20.51B	+17.3%
Dec 2013	$17.49B	-3.8%
Sep 2013	$18.17B	+0.4%
Jun 2013	$18.10B	+13.0%
Mar 2013	$16.02B	-0.7%
Dec 2012	$16.14B	-10.9%
Sep 2012	$18.12B	+3.8%
Jun 2012	$17.45B	+12.1%
Mar 2012	$15.57B	+4.0%
Dec 2011	$14.97B	-3.9%
Sep 2011	$15.58B	+11.4%
Jun 2011	$13.98B	+7.3%
Mar 2011	$13.03B	+6.8%
Dec 2010	$12.20B	+14.8%
Sep 2010	$10.62B	+6.9%
Jun 2010	$9.94B	+1.7%

Month	Value	Change
Mar 2010	$9.78B	+1.8%
Dec 2009	$9.60B	-56.8%
Sep 2009	$22.26B	+31.4%
Jun 2009	$16.93B	+34.6%
Mar 2009	$12.58B	+129.3%
Dec 2008	$5.49B	-19.8%
Sep 2008	$6.84B	-31.5%
Jun 2008	$9.99B	+9.0%
Mar 2008	$9.16B	+11.3%
Dec 2007	$8.23B	+11.4%
Sep 2007	$7.39B	+34.3%
Jun 2007	$5.50B	+35.7%
Mar 2007	$4.06B	-53.4%
Dec 2006	$8.71B	-4.1%
Sep 2006	$9.09B	-13.2%
Jun 2006	$10.46B	-15.6%
Mar 2006	$12.40B	-20.7%
Dec 2005	$15.64B	+11.5%
Sep 2005	$14.03B	+7.7%
Jun 2005	$13.03B	+38.1%
Mar 2005	$9.44B	+149.7%
Sep 1999	$3.78B	+6.7%
Jun 1999	$3.54B	+14.4%
Mar 1999	$3.10B	-22.9%
Sep 1998	$4.01B	+42.9%
Mar 1998	$2.81B	+149.7%
Dec 1997	$1.13B	-12.2%
Sep 1997	$1.28B	-19.2%
Jun 1997	$1.59B	-8.6%
Mar 1997	$1.74B	+28.4%
Dec 1996	$1.35B	+0.6%
Sep 1996	$1.34B	-20.3%
Jun 1996	$1.69B	-3.8%
Mar 1996	$1.75B	-5.1%
Dec 1995	$1.85B	-3.1%
Sep 1995	$1.91B	+14.5%
Jun 1995	$1.66B	-25.1%
Mar 1995	$2.22B	+38.5%
Dec 1994	$1.60B	+32.2%
Sep 1994	$1.21B	-0.5%
Jun 1994	$1.22B	+33.0%
Mar 1994	$917.00M	+10.6%
Dec 1993	$829.40M	-30.7%
Sep 1993	$1.20B	+41.2%
Jun 1993	$847.80M	+20.7%
Mar 1993	$702.50M	+22.2%
Dec 1992	$575.10M	-33.8%
Sep 1992	$868.80M	+21.4%
Jun 1992	$715.90M	+3.0%
Mar 1992	$694.80M	-12.9%
Dec 1991	$797.90M	-13.3%
Sep 1991	$920.30M	+28.1%
Jun 1991	$718.20M	-7.8%
Mar 1991	$779.20M	-3.4%
Dec 1990	$806.40M	+24.5%
Sep 1990	$647.60M	+15.5%
Jun 1990	$560.80M	+10.2%
Mar 1990	$508.70M	-25.7%
Dec 1989	$685.10M	+9.8%
Sep 1989	$623.80M	-59.8%
Dec 1988	$1.55B	+35.0%
Dec 1987	$1.15B	+18.9%
Dec 1986	$965.80M	+14.7%
Dec 1985	$842.00M	+13.1%
Dec 1984	$744.30M	-

FAQ

What is the current quarterly cash & cash equivalents of MRK?: As of today, MRK quarterly cash & cash equivalents is $7.18B
What is MRK quarterly cash & cash equivalents most recent change?: MRK quarterly cash & cash equivalents was up +24.41% on June 30, 2026
What is 1-year change in MRK quarterly cash & cash equivalents?: MRK quarterly cash & cash equivalents is down -17.11% year-over-year
How far is MRK quarterly cash & cash equivalents from its all-time high?: MRK quarterly cash & cash equivalents is currently -67.73% below its historical high of $22.26B set on September 30, 2009
How does MRK quarterly cash & cash equivalents rank versus sector peers?: MRK quarterly cash & cash equivalents is higher than 98.67% of companies in Healthcare sector
When is MRK next earnings release?: The next earnings release for MRK is on October 29, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

MRK Official Website www.merck.com
MRK Profile on Yahoo Finance finance.yahoo.com/quote/MRK
MRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrk